Tag: Patient Safety

Study: Psilocybin therapy reduces depression in frontline clinicians

JAMA (healthcare publication) Network logo

Editor's Note Psilocybin therapy significantly reduces symptoms of depression in frontline clinicians who experienced psychological distress during the COVID-19 pandemic, according to a randomized clinical trial published December 5 in JAMA Network Open.   The trial enrolled 30 clinicians, including physicians, advanced practice practitioners (APPs), and nurses, who provided frontline care…

Read More

By: Matt Danford
December 19, 2024
Share

Study: Surgeries improve survival in young BRCA-positive breast cancer patients

Editor's Note Preliminary research shows removing breasts or ovaries can significantly improve survival and reduce recurrence risk in young breast cancer patients with BRCA mutations, HealthDay reported December 13. The findings were presented this week at the San Antonio Breast Cancer Symposium. According to the article, researchers analyzed data from…

Read More

By: Matt Danford
December 19, 2024
Share

Study: Advanced recovery room care could reduce long-term postoperative mortality

Editor's Note Findings from The ARRC II study show using advanced recovery room care (ARRC) for medium-risk surgical patients significantly reduces 18-month postoperative mortality compared to standard ward care. As detailed in a December 11 research letter in JAMA Surgery, this benefit appears linked to minimizing early postoperative complications, which…

Read More

By: Matt Danford
December 19, 2024
Share

FDA designates Class 1 recalls for balloon catheters, radiographic markers

Editor's Note Balloon catheters for atrial fibrillation patients and implantable radiographic markers were the subjects of separate US Food and Drug Administration (FDA) Class 1 recalls—the most severe category indicating risk of serious injury or death—announced on December 18. The first recall involves Boston Scientific’s POLARx Cryoablation devices. Higher-than-anticipated reports…

Read More

By: Matt Danford
December 19, 2024
Share

Anthem’s anesthesia time limit policy, reversal sparks new legislation

Editor's Note Anthem Blue Cross Blue Shield recently reversed its controversial plan to impose time limits on anesthesia coverage after intense backlash from the medical community, including anesthesiologists and patient advocates. The policy, aimed at curbing alleged overbilling, would have restricted payments based on average surgery times, a move critics…

Read More

By: Tarsilla Moura
December 18, 2024
Share

Study: Geriatric surgery program improves outcomes, independence

Editor's Note Older cancer patients undergoing major abdominal procedures at Roger Williams Medical Center in Providence, Rhode Island, significantly benefitted from the American College of Surgeons (ACS) Geriatric Surgery Verification (GSV) program, Medical Xpress reported December 10. Citing a study published in the Journal of the American College of Surgeons,…

Read More

By: Matt Danford
December 18, 2024
Share

Milestone pig kidney transplant offers hope amid ethical, safety questions

Editor's Note A 53-year-old woman with end-stage kidney failure became the first living person to receive a genetically modified pig kidney in a milestone surgery at NYU Langone Health, NPR reported December 17. Although the experimental procedure marks significant progress toward addressing organ shortages, it also drew commentary on ongoing…

Read More

By: Matt Danford
December 17, 2024
Share

Annual Leapfrog Group awards recognize top hospitals, ASCs

Editor's Note The Leapfrog Group has announced its 2024 Top Hospital and Top Ambulatory Surgery Center (ASC) Award recipients December 17, honoring facilities for standout performance in patient safety and care quality. This year, the national employer watchdog organization named 134 hospitals and 31 ASCs as winners of the national…

Read More

By: Matt Danford
December 17, 2024
Share

Study: Active monitoring without surgery safe for certain low-risk DCIS patients

Editor's Note Active monitoring for certain breast cancer patients offers similar outcomes to surgery with fewer side effects, according to research detailed in a December 16 article from Oncology News Central. Presented at the 2024 San Antonio Breast Cancer Symposium and published in JAMA, The COMET trial supports the safety…

Read More

By: Matt Danford
December 16, 2024
Share

Data support option to skip sentinel lymph node biopsy in early breast cancer

Editor's Note Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative early breast cancer provides noninferior outcomes compared to undergoing the procedure, MedPage Today reported December 13. Presented at the San Antonio Breast Cancer Symposium and published in the New England Journal of Medicine, the INSEMA trial found…

Read More

By: Matt Danford
December 16, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat